Methylprednisolone And Methylprednisolone Acetate And Methylprednisolo



Indications and Reactions:

Role Indications Reactions
Primary
Non-hodgkin's Lymphoma 22.9%
Immunosuppression 15.3%
Renal Transplant 7.6%
Extranodal Nk/t-cell Lymphoma, Nasal Type 5.3%
Microscopic Polyangiitis 4.7%
Acute Lymphocytic Leukaemia 4.1%
Heart Transplant Rejection 3.5%
Multiple Sclerosis 3.5%
Pneumonia 3.5%
Raynaud's Phenomenon 3.5%
Scleroderma 3.5%
Lichen Sclerosus 2.9%
T-cell Lymphoma Stage Iv 2.9%
Crohn's Disease 2.4%
Graft Versus Host Disease 2.4%
Hepatitis Fulminant 2.4%
Idiopathic Thrombocytopenic Purpura 2.4%
Liver Transplant 2.4%
Rheumatoid Arthritis 2.4%
Vasculitis 2.4%
Neutropenia 11.3%
Strongyloidiasis 9.7%
Respiratory Failure 8.1%
Atrial Fibrillation 6.5%
Pancreatitis Acute 6.5%
Dysmorphism 4.8%
Fungal Endocarditis 4.8%
Multi-organ Failure 4.8%
Neutropenic Sepsis 4.8%
Progressive Multifocal Leukoencephalopathy 4.8%
Tachycardia 4.8%
Bronchopulmonary Aspergillosis 3.2%
Cerebral Ischaemia 3.2%
Herpes Simplex 3.2%
Meningitis Cryptococcal 3.2%
Myelopathy 3.2%
Myocardial Infarction 3.2%
Neonatal Respiratory Distress Syndrome 3.2%
Neuromyelitis Optica 3.2%
Nocardiosis 3.2%
Secondary
Acute Lymphocytic Leukaemia 14.0%
Graft Versus Host Disease 8.0%
Endocrine Ophthalmopathy 6.0%
Glomerulonephritis 6.0%
Intestinal T-cell Lymphoma Stage I 6.0%
Myxoedema 6.0%
Non-hodgkin's Lymphoma 6.0%
Scleroderma 6.0%
Aspergillosis 4.0%
Autoimmune Disorder 4.0%
Castleman's Disease 4.0%
Hypergammaglobulinaemia 4.0%
Microscopic Polyangiitis 4.0%
Multiple Sclerosis 4.0%
Musculoskeletal Pain 4.0%
Pulmonary Alveolar Haemorrhage 4.0%
Type 2 Diabetes Mellitus 4.0%
Anaemia Haemolytic Autoimmune 2.0%
Arthritis 2.0%
Eosinophilic Pneumonia 2.0%
Leukocytosis 13.0%
White Blood Cell Count Increased 13.0%
Bronchopulmonary Aspergillosis 8.7%
Hyperglycaemia 4.3%
Intra-abdominal Haemorrhage 4.3%
Lymphopenia 4.3%
Multi-organ Failure 4.3%
Muscular Dystrophy 4.3%
Muscular Weakness 4.3%
Neutropenic Sepsis 4.3%
Pneumatosis Intestinalis 4.3%
Post Transplant Distal Limb Syndrome 4.3%
Pulmonary Tuberculosis 4.3%
Respiratory Tract Infection 4.3%
Reversible Posterior Leukoencephalopathy Syndrome 4.3%
Tuberculosis 4.3%
Ventricular Fibrillation 4.3%
Weight Decreased 4.3%
Interacting
Acne 33.3%
Headache 33.3%
Hypersensitivity 33.3%
Urticaria 100.0%